Nuclera Secures $75 Million in Series C Financing to Transform Protein Discovery

In a significant boost for biotechnology innovation, Nuclera has successfully closed a $75 million financing round, aimed at advancing its groundbreaking eProtein Discovery platform. This Series C round was led by Elevage Medical Technologies and saw participation from various prominent investors, including Patient Square Capital, British Patient Capital, Cambridge Innovation Capital, and others. This substantial…

Read More

Halo Industries Raises $80 Million to Revolutionize Semiconductor Manufacturing

Halo Industries, Inc., a pioneer in laser manufacturing technology for the semiconductor sector, has successfully closed its oversubscribed Series B funding round, securing up to $80 million. The round was led by Thomas Tull’s U.S. Innovative Technology Fund (USIT), alongside investments from 8VC and SAIC. This substantial funding infusion will accelerate Halo Industries’ efforts to…

Read More

Streetbeat Bags $15 Million to Scale Its AI-Powered Transformation of Wealth Advisory

When Streetbeat began its journey three years ago, the idea of a machine parsing market movements, client emotions, and portfolio risk simultaneously sounded ambitious—even indulgent. But today, the Palo Alto–based startup is reshaping what advisory work looks like in financial institutions. And investors are taking notice. The company has raised $15 million in a Series…

Read More

Infinitus Systems Secures $51.5 Million in Series C Funding to Transform Healthcare with AI

Infinitus Systems, Inc., the trailblazer in automating manual healthcare phone operations, has successfully raised $51.5 million in Series C funding, spearheaded by Andreessen Horowitz. This investment round also includes participation from Memorial Hermann Health System and existing investors such as Kleiner Perkins, Coatue, and GV (Google Ventures), bringing the company’s total funding to an impressive…

Read More

Brands Must Reclaim Their Voice as AI Becomes the New Search Frontier: Search Party Raises $3.5M to Lead the Charge

In an era where artificial intelligence is swiftly eclipsing traditional search engines, a fresh startup, Search Party, emerges with ambitions to redefine how brands assert their presence in AI-driven discovery. The San Francisco-based company announced its public debut, backed by a $3.5 million seed round led by Fuse, a venture capital firm known for nurturing…

Read More

OpenAI-Backed Speak Raises $20M in Series B Extension, Doubling Valuation to $500M

AI-powered language learning app, Speak, has secured $20 million in a Series B extension, doubling its valuation to $500 million. This round, led by Buckley Ventures and supported by the OpenAI Startup Fund, Khosla Ventures, Y Combinator co-founder Paul Graham, and LinkedIn executive chairman Jeff Weiner, reflects the company’s rapid growth and investor confidence. Since…

Read More
cureosity_team

CUREOSITY Secures €3.8 Million Investment to Propel VR Therapy Innovations

In a significant stride towards revolutionizing therapeutic interventions, medtech innovator CUREOSITY has announced securing an additional €3.8 million in funding, catapulting its total investment to over €8.4 million. Specializing in the development of virtual reality (VR) therapy enhanced by gamification, CUREOSITY integrates cutting-edge neuroscientific discoveries, particularly harnessing the power of neuroplasticity, with decades of therapeutic…

Read More

Valneva’s Breakthrough: Canada Approves World’s First Chikungunya Vaccine

Valneva SE has achieved a historic milestone with Health Canada’s approval of the world’s first chikungunya vaccine. Following its successful launch in the U.S. and pending European authorization, this decision underscores IXCHIQ®’s pivotal role in global healthcare strategy. Chikungunya, a mosquito-borne virus causing severe joint pain and fever, poses a significant public health threat with…

Read More

ArsenalBio Raises $325 Million in Landmark Series C Round to Accelerate Breakthrough Cell Therapies for Solid Tumors

Arsenal Biosciences, Inc. (ArsenalBio), a pioneering force in programmable cell therapy, has announced the successful closure of an oversubscribed $325 million Series C financing round. This significant funding boost reflects a growing confidence in ArsenalBio’s innovative approach to advanced CAR T-cell therapies targeting solid tumors. The Series C round attracted a host of new investors,…

Read More

Movate Appoints Dariyus Setna as EVP and Chief Revenue Officer for Digital Services

Movate, a leading digital technology and customer experience (CX) services provider, has named Dariyus Setna as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO) for Digital Services. Setna, a seasoned business leader with over 25 years of experience, joins Movate from Globant, where he significantly contributed to quadrupling revenue and increasing market…

Read More